Dimethyl-carbamic acid 4-[(S)-1-methylamino-3-(4-nitro-phenoxy)-propyl]-phenyl ester

ID: ALA194372

Chembl Id: CHEMBL194372

PubChem CID: 6918635

Max Phase: Preclinical

Molecular Formula: C19H23N3O5

Molecular Weight: 373.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN[C@@H](CCOc1ccc([N+](=O)[O-])cc1)c1ccc(OC(=O)N(C)C)cc1

Standard InChI:  InChI=1S/C19H23N3O5/c1-20-18(12-13-26-16-10-6-15(7-11-16)22(24)25)14-4-8-17(9-5-14)27-19(23)21(2)3/h4-11,18,20H,12-13H2,1-3H3/t18-/m0/s1

Standard InChI Key:  BGGBDKDNDXWHQP-SFHVURJKSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ache Acetylcholinesterase (1323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a4 Serotonin transporter (6087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ache Acetylcholinesterase (2577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.41Molecular Weight (Monoisotopic): 373.1638AlogP: 3.38#Rotatable Bonds: 8
Polar Surface Area: 93.94Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.07CX LogP: 2.96CX LogD: 1.29
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -0.82

References

1. Morphy R, Rankovic Z..  (2005)  Designed multiple ligands. An emerging drug discovery paradigm.,  48  (21): [PMID:16220969] [10.1021/jm058225d]
2. Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C..  (2008)  Multi-target-directed ligands to combat neurodegenerative diseases.,  51  (3): [PMID:18181565] [10.1021/jm7009364]
3. Zhou J, Jiang X, He S, Jiang H, Feng F, Liu W, Qu W, Sun H..  (2019)  Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.,  62  (20): [PMID:31082225] [10.1021/acs.jmedchem.9b00017]
4. Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z..  (2022)  Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.,  240  [PMID:35858523] [10.1016/j.ejmech.2022.114606]

Source